AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2020
Feb 27, 2020
33819_dirs_2020-02-27_7df2bd40-ccf6-4630-bc07-da361d6e108d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2020-02-25
Reporting Person: Gadot Harel (Director, Chairman, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-25 | Stock Option (Right to Buy) | $9.64 | A | 166666 | Acquired | 2030-02-25 | Common Stock, par value $0.01 per share (166666) | Direct |
More from Microbot Medical Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 10